Status:
RECRUITING
Falcon Real World Evidence Registry
Lead Sponsor:
Exact Sciences Corporation
Conditions:
Cancer
Eligibility:
All Genders
50-80 years
Brief Summary
This is a multi-site registry of patients receiving the Exact Sciences Multicancer Early Detection (MCED) test.
Detailed Description
This study was designed to simulate a real-world application of Exact Science's Multicancer Early Detection (MCED) test. Participants will be offered the Exact Science's MCED test annually for 3 years...
Eligibility Criteria
Inclusion
- Participant age at time of consent is between 50 and 80 years
- Agree to receive the Exact Sciences MCED test and follow-up imaging
- Willing and able to provide informed consent
- Access to a suitable technology and willing to complete surveys electronically
Exclusion
- Any invasive tumor (excluding non-melanoma skin cancers) or hematological malignancy in the previous three years or current suspicion of cancer and/or in active treatment (e.g., chemotherapy, radiation therapy, immunotherapy, and/or surgery
Key Trial Info
Start Date :
August 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2031
Estimated Enrollment :
25000 Patients enrolled
Trial Details
Trial ID
NCT06589310
Start Date
August 1 2024
End Date
January 1 2031
Last Update
May 31 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Endeavor Health
Evanston, Illinois, United States, 60201
2
Baylor Scott & White Health
Dallas, Texas, United States, 75246